We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCFS icon
7251
CALL
FirstCash
FCFS
$9.05B
$749K ﹤0.01%
+10,700
New +$678K
RFDI icon
7252
First Trust RiverFront Dynamic Developed International ETF
RFDI
$167M
$749K ﹤0.01%
11,629
-17,271
-60% -$1.03M
IMAX icon
7253
PUT
IMAX
IMAX
$2.81B
$748K ﹤0.01%
41,500
-48,800
-54% -$672K
MDXG icon
7254
MiMedx Group
MDXG
$622M
$748K ﹤0.01%
+82,412
New +$593K
JLS icon
7255
Nuveen Mortgage and Income Fund
JLS
$94.9M
$747K ﹤0.01%
+37,763
New +$721K
MCY icon
7256
CALL
Mercury Insurance
MCY
$5.92B
$747K ﹤0.01%
14,300
+2,000
+16% +$89.4K
TCX icon
7257
CALL
Tucows
TCX
$142M
$746K ﹤0.01%
10,100
-11,100
-52% -$826K
CSPR
7258
CALL
DELISTED
Casper Sleep Inc.
CSPR
$746K ﹤0.01%
121,300
+75,200
+163% +$515K
DEM icon
7259
CALL
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
$745K ﹤0.01%
18,100
-3,600
-17% -$138K
LZB icon
7260
PUT
La-Z-Boy
LZB
$1.66B
$745K ﹤0.01%
18,700
-75,700
-80% -$2.8M
MDGL icon
7261
PUT
Madrigal Pharmaceuticals
MDGL
$11.9B
$745K ﹤0.01%
6,700
-3,000
-31% -$367K
PARAA
7262
DELISTED
Paramount Global Class A
PARAA
$745K ﹤0.01%
19,691
-14,449
-42% -$483K
RSPH icon
7263
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$794M
$745K ﹤0.01%
28,480
-108,530
-79% -$2.7M
CBT icon
7264
Cabot Corp
CBT
$4.46B
$744K ﹤0.01%
+16,584
New +$688K
CM icon
7265
Canadian Imperial Bank of Commerce
CM
$109B
$744K ﹤0.01%
17,398
-317,230
-95% -$12.9M
GFL icon
7266
CALL
GFL Environmental
GFL
$14.9B
$744K ﹤0.01%
25,500
-9,200
-27% -$225K
QYLD icon
7267
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.27B
$744K ﹤0.01%
+32,628
New +$722K
RGNX icon
7268
CALL
Regenxbio
RGNX
$688M
$744K ﹤0.01%
16,400
-13,600
-45% -$475K
ARAY icon
7269
Accuray
ARAY
$34.9M
$743K ﹤0.01%
178,386
-177,321
-50% -$651K
CSML
7270
DELISTED
IndexIQ ETF Trust IQ U.S. Small Cap ETF
CSML
$743K ﹤0.01%
+25,473
New +$661K
DX
7271
PUT
Dynex Capital
DX
$3.17B
$742K ﹤0.01%
41,700
-8,400
-17% -$144K
IQDF icon
7272
FlexShares International Quality Dividend Index Fund
IQDF
$1.17B
$742K ﹤0.01%
+30,701
New +$686K
PEX icon
7273
ProShares Global Listed Private Equity ETF
PEX
$11.5M
$742K ﹤0.01%
23,197
+4,360
+23% +$128K
SPXU icon
7274
PUT
ProShares UltraPro Short S&P 500
SPXU
$384M
$741K ﹤0.01%
1,251
-931
-43% -$668K
KDNY
7275
PUT
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$741K ﹤0.01%
46,700
+44,700
+2,235% +$674K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.